Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC).

导出 LinkOut

翻译打印收藏纠错

第一作者： Ankur,Bahl

第一单位： Department of Medical Oncology, Max Super Speciality Hospital, New Delhi, India.

作者： Ankur,Bahl ^[1] ; Vineet,Talwar ^[2] ; Bhawna,Sirohi ^[1] ; Prashant,Mehta ^[3] ; Devavrat,Arya ^[1] ; Gunjan,Shrivastava ^[1] ; Akhil,Dahiya ^[4] ; K,Pavithran ^[5]

作者单位： Department of Medical Oncology, Max Super Speciality Hospital, New Delhi, India. ^[1] Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India. ^[2] Department of Medical Oncology, Asian Institute of Medical Sciences, Faridabad, India. ^[3] Medical Affairs, Dr. Reddy's Laboratories Limited, Hyderabad, India. ^[4] Department of Medical Oncology, Amrita Institute of Medial Sciences and Research Centre, Kochi, India. ^[5]

关键词 Bevacizumab Cetuximab Panitumumab adenocarcinoma anti-EGFR mAb colorectal cancer (CRC)primary tumor location tumor sidedness

DOI 10.3389/fonc.2020.00964

PMID 32612957

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Frontiers in oncology

2020年10卷

964页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC).

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC).

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除